Microbiology & Pathology in Washington

Kamiya Biomedical Company manufactures clinical diagnostics assay reagents, research ELISAs, antibodies, and biochemicals for laboratory and preclinical use. Primary product lines include immunoassay and immunoturbidimetric reagents adapted to most major automated chemistry analyzers (Roche Cobas, Hitachi, Beckman, Olympus, Siemens, Abbott, and others), spanning rheumatoid factor, C-reactive protein, D-dimer, ferritin, immunoglobulins, β-2 microglobulin, microtransferrin, vitamin C, apolipoprotein assays, H. pylori testing, and KL-6 measurement. The company also manufactures thousands of ELISA kits for human research and preclinical/animal testing across 20+ species (mouse, rat, dog, cat, primate, bovine, porcine, avian, and others). Secondary offerings include 1,300+ monoclonal and polyclonal antibodies; 200+ biochemicals (recombinants, substrates, inhibitors, polymerases); and laboratory testing services for lipid and vitamin C analysis. Several assays carry regulatory status for clinical diagnostics (ISO 13485, CE Mark), while others are designated research-use-only in the US. The company also produces animal assay reagents for veterinary diagnostics (dog CRP, cat serum amyloid A) and has developed COVID-19 response reagents. Founded in 1983, Kamiya serves clinical laboratories, research institutions, and preclinical/pharmaceutical development markets. Manufacturing capabilities include custom antibody production, ELISA kit formulation, and reagent adaptation to third-party chemistry analyzer platforms.

Gangdong Group Co., Ltd. is a South Korean manufacturer specializing in histopathology reagents and consumables. The company develops and supplies dedicated chemistry solutions optimized for tissue pathology laboratories and hospitals, serving approximately 130 healthcare institutions and research facilities. Primary product lines include GD CHEM (histopathology-specific reagents), GD LABWARE (histopathology consumables), FIXUP™ (a formaldehyde-alternative fixative designed to improve workplace safety by eliminating exposure to Group 1 carcinogenic compounds), and SSN Solutions (optimized staining reagent systems). The company emphasizes years of accumulated histopathology expertise and testing data to inform product development. Gangdong Group also offers OEM/ODM and MRO services. Recent collaborations include joint development of microtome blades with Doruko. The company addresses occupational health concerns in pathology labs by providing safer chemical alternatives to traditional formaldehyde-based fixatives while maintaining diagnostic quality for research and clinical diagnostic applications.

US BioTek Laboratories is a functional and integrative medicine diagnostic laboratory specializing in precision testing for naturopathic doctors, functional medicine practitioners, and integrative healthcare providers. The company operates a CLIA-certified and CAP-accredited laboratory offering comprehensive testing panels across six primary areas: Food Sensitivity Testing (IgG antibody assessment), GI Microbiome Testing (bacterial composition and metabolite analysis), Environmental Toxin Testing (mycotoxins, glyphosate, and pollutant detection), Food Allergy Testing (IgE antibody profiling), Organic Acids Testing (metabolic markers including NAD/NADH), and Hormone Testing (steroid and other hormonal markers). Their VeriTek™ quality assurance methodology emphasizes automated systems, superior assay preparation, duplicate testing protocols, and external accreditation to ensure reproducible results. The company provides collection kits with prepaid return shipping, rapid turnaround times, and results delivery via a provider portal. US BioTek serves the functional medicine and naturopathic medicine markets and recently completed a merger with NutriPATH Pathology to expand service offerings. The laboratory is positioned for practitioners seeking specialty diagnostic tools to guide precision treatment recommendations and is particularly utilized in anti-aging medicine, gastrointestinal health assessment, hormone optimization, and environmental toxicology.

Molecular Testing Labs is a CLIA-certified and CAP-accredited clinical laboratory operating facilities in Vancouver, WA (CLIA# 50D2050397, CAP# 8690528) and Irving, TX (CLIA# 45D2278063, CAP# 9607237). The company processes hundreds of thousands of diagnostic tests monthly on both clinically and non-clinically collected samples. Their scientific team includes world-class clinicians, PhDs, research scientists, and diagnostic technicians focused on advancing diagnostic accessibility and equity in healthcare. MLT offers end-to-end diagnostic services across multiple therapeutic and clinical areas. Core service lines include comprehensive drug testing and toxicology screening with confirmation methodologies, GLP-1 weight management adherence testing using advanced diagnostics to monitor treatment efficacy, and population health testing solutions designed to close care gaps and improve health outcomes. They provide tailored solutions for diverse markets including clinics, digital health companies, public health departments, research universities, and telehealth platforms. The company emphasizes quality systems, compliance leadership, and patient-centered diagnostics. Their operations include sample logistics, specimen handling, and results reporting integrated with clinical workflows. MTL maintains rigorous quality measures, continuous compliance training, and auditing protocols. The organization is committed to making diagnostic care accessible while maintaining stringent regulatory adherence and ethical standards across all testing operations.

STEMCELL Technologies is a life science research company that provides innovative reagents, tools, and services for cell isolation, culture, and assay applications. The company serves academic, clinical, and industrial research laboratories globally with product portfolios spanning immunology, organoid research, hematopoietic cell research, pluripotent stem cell research, cell therapy, and neuroscience research. Their offerings include specialized cell culture media, isolation reagents, and assay tools designed for specific tissue and cell types. The company maintains dedicated scientific support services and offers training programs, including GMP-compliant Human T Cell Expansion courses. STEMCELL also provides diagnostic partnerships and OEM solutions for institutions requiring customized research reagents and protocols. Manufacturing and quality capabilities support laboratory and clinical research applications. The organization operates with a stated mission of "scientists helping scientists" and emphasizes technical expertise and customer collaboration in advancing research outcomes.

VMRD, Inc. is a veterinary diagnostic manufacturer founded in 1981, headquartered in Pullman, Washington. The company develops and manufactures USDA-licensed ELISA kits, immunofluorescence assay reagents, antibodies, point-of-care diagnostic products, and automated ELISA processing systems. VMRD distributes diagnostic solutions to over 77 countries and serves the veterinary, pharmaceutical, and biologics industries. The company's Testing Services division (formerly ABR) provides comprehensive adventitious agent testing for raw materials, cells, and seeds, including mycoplasma testing, sterility testing, and regulatory viral screening to support compliance and quality assurance requirements. Additional product lines include CWD RT-QuIC reagents for prion detection and nucleic acid extraction kits for molecular applications. With over 50 researchers and technicians, VMRD combines diagnostic innovation with specialized testing services for regulatory and pharmaceutical applications.